We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,083 results
  1. Hypersensitivity Pneumonitis: A Silent Epidemic?

    Purpose of Review

    Hypersensitivity pneumonitis (HP), along with interstitial lung disease as a whole, is a disorder with rising incidence, morbidity,...

    Kavitha Selvan, Cathryn T. Lee in Current Pulmonology Reports
    Article 25 May 2024
  2. Concurrent features of sarcoidosis and hypersensitivity pneumonitis in two patients exposed to fungal antigens

    Background

    Sarcoidosis and hypersensitivity pneumonitis (HP) are two distinct clinical entities that share granulomatous inflammation, although each...

    Almerico Marruchella, Paola Faverio, Fabrizio Luppi in BMC Pulmonary Medicine
    Article Open access 04 November 2023
  3. Role of transforming growth factor beta in assessment of severity of hypersensitivity pneumonitis: a single center study

    Background

    Hypersensitivity pneumonitis (HP) is a more frequently diagnosed picture of diffuse parenchymal lung disease. It is an inflammation of the...

    Yasmine H. EL Hinnawy, Aymen S. Salem, ... Naglaa B. Ahmed in The Egyptian Journal of Bronchology
    Article Open access 11 May 2024
  4. New Paradigms in Hypersensitivity Pneumonitis

    Purpose of Review

    This review aims to briefly discuss the new paradigms explored in the recent past especially for the diagnosis and treatment of...

    Bineet Ahluwalia, Sheetu Singh in Current Pulmonology Reports
    Article 08 October 2022
  5. Phenotypic subtypes of fibrotic hypersensitivity pneumonitis identified by machine learning consensus clustering analysis

    Background

    Patients with fibrotic hypersensitivity pneumonitis (f-HP) have varied clinical and radiologic presentations whose associated phenotypic...

    Tananchai Petnak, Wisit Cheungpasitporn, ... Teng Moua in Respiratory Research
    Article Open access 18 January 2024
  6. Predictors of pulmonary hypertension in patients with hypersensitivity pneumonitis

    Background

    Hypersensitivity pneumonitis (HP) is an immunologically induced inflammation of the lung parenchyma that occurs in susceptible individuals...

    Mohamed Abdelhakim Elnady, Reem Elkorashy, ... Eman Kamal Ibrahim in BMC Pulmonary Medicine
    Article Open access 09 February 2023
  7. Updates in Hypersensitivity Pneumonitis: A Narrative Review

    Purpose of Review

    Hypersensitivity pneumonitis (HP) is an immune-mediated disease triggered by a known or unknown antigen. While reversible in the...

    Javeria Anwar, Wing Tai Kong, Bathmapriya Balakrishnan in Current Pulmonology Reports
    Article Open access 08 September 2022
  8. Assessment of clinical relevance of antigen improves diagnostic accuracy of hypersensitivity pneumonitis

    Background

    Exposure assessment is integral to the diagnosis of hypersensitivity pneumonitis (HP). Although the clinical relevance of exposed antigens...

    Yuki Iijima, Masaru Ejima, ... Yasunari Miyazaki in BMC Pulmonary Medicine
    Article Open access 14 February 2024
  9. Hypersensitivity pneumonitis: new concepts and classifications

    The clinical and pathologic diagnosis of hypersensitivity pneumonitis has been confounded by conflicting definitions, with two recent guidelines...

    Andrew Churg in Modern Pathology
    Article 16 September 2021
  10. Vascular endothelial growth factor in hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung disease

    Background

    A growing evidence on the role of vascular endothelial growth factor (VEGF) in the pathogenesis of interstitial lung diseases accumulated...

    Yasmine Hamdy El-Hinnawy, Nehal El-Ghobashy, ... Gihan Saad Abo Elwafa in The Egyptian Journal of Bronchology
    Article Open access 09 May 2024
  11. The effectiveness and pharmacoeconomic study of using different corticosteroids in the treatment of hypersensitivity pneumonitis

    Purpose

    Interstitial lung diseases (ILDs) are caused by inflammation and/or fibrosis of alveolar walls resulting in impaired gas exchange....

    Marwa G. Elhennawy, Yosri Akl, ... Nirmeen A. Sabry in BMC Pulmonary Medicine
    Article Open access 15 February 2024
  12. Longitudinal changes in serum immunoglobulin G testing in patients with fibrotic avian hypersensitivity pneumonitis

    Background

    Evaluation of the antigen responsible for fibrotic hypersensitivity pneumonitis (HP) is challenging. Serum immunoglobulin (Ig) G testing...

    Ryo Okuda, Tamiko Takemura, ... Takashi Ogura in BMC Pulmonary Medicine
    Article Open access 18 May 2024
  13. Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis

    Background

    The distinction between hypersensitivity pneumonitis (HP) and idiopathic pulmonary fibrosis (IPF) was thought to be important due to the...

    Traci N. Adams, Kiran Batra, ... Craig S. Glazer in BMC Pulmonary Medicine
    Article Open access 22 June 2023
  14. Clusters of comorbidities in fibrotic hypersensitivity pneumonitis

    Background

    Hypersensitivity pneumonitis (HP) is a type of interstitial lung disease (ILD) with a variable disease course and prognosis ranging from...

    Thomas Skovhus Prior, Julia Wälscher, ... Michael Kreuter in Respiratory Research
    Article Open access 21 December 2022
  15. Hypersensitivity Pneumonitis With and Without Autoimmune Features: A Clinical Comparative Analysis

    Background

    Hypersensitivity pneumonitis (HP) is an interstitial lung disease (ILD) caused by an immunological reaction to repeated inhalational...

    Saminder Singh Kalra, Johnny F. Jaber, ... Divya Patel in Lung
    Article 18 October 2022
  16. Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study

    Background

    Idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis share commonalities in pathogenesis shifting haemostasis...

    Małgorzata Sobiecka, Monika Szturmowicz, ... Witold Tomkowski in BMC Pulmonary Medicine
    Article Open access 17 December 2021
  17. Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase

    Background

    The antigen avoidance has been used in the diagnosis and treatment of hypersensitivity pneumonitis (HP); however, its usefulness in stable...

    Ryo Okuda, Tamiko Takemura, ... Takashi Ogura in Allergy, Asthma & Clinical Immunology
    Article Open access 09 December 2022
  18. Pediatric hypersensitivity pneumonitis: literature update and proposal of a diagnostic algorithm

    Hypersensitivity pneumonitis (HP) is a rare disease in childhood with the prevalence of 4 cases per 1 million children and an incidence of 2 cases...

    Carla Mastrorilli, Luca Pecoraro, ... Elio Novembre in Italian Journal of Pediatrics
    Article Open access 28 March 2022
  19. High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study

    Background

    Asbestosis and fibrotic hypersensitivity pneumonitis (FHP) share the pathogenetic mechanisms induced bronchiolocentric fibrotic process...

    Ruimin Ma, Shuang Li, ... Qiao Ye in BMC Pulmonary Medicine
    Article Open access 25 May 2022
  20. A first look at the reliability, validity and responsiveness of L-PF-35 dyspnea domain scores in fibrotic hypersensitivity pneumonitis

    Background

    Dyspnea impairs quality of life (QOL) in patients with fibrotic hypersensitivity pneumonitis (FHP). The Living with Pulmonary Fibrosis...

    Jeffrey J. Swigris, Kerri Aronson, Evans R. Fernández Pérez in BMC Pulmonary Medicine
    Article Open access 19 April 2024
Did you find what you were looking for? Share feedback.